Butterfly Network IPO
Butterfly Network develops portable ultrasound devices using semiconductor technology, making medical imaging more accessible and affordable. The company's handheld Butterfly iQ device connects to smartphones and has FDA approval for multiple clinical applications. The IPO attracted investor interest due to its potential to democratize medical imaging globally.
What We Know
Butterfly Network went public in February 2021 through a SPAC merger with Longview Acquisition Corp, trading on NYSE under the ticker BFLY. The transaction valued the company at approximately $1.5 billion. Since going public, Butterfly Network's stock performance has been volatile, reflecting broader market sentiment toward growth-stage medical device companies. The company has continued to expand its portable ultrasound platform and pursue regulatory approvals in new markets, while working toward profitability as a public company.
Frequently Asked Questions
Has Butterfly Network had an IPO?
Yes, Butterfly Network completed its IPO in February 2021 through a SPAC merger. The company has been publicly traded on the NYSE under ticker BFLY since then.
When is the Butterfly Network IPO date?
Butterfly Network already completed its IPO in February 2021. The company went public through a merger with Longview Acquisition Corp.
How can I buy Butterfly Network stock?
You can buy Butterfly Network stock through any brokerage account under the ticker symbol BFLY on the NYSE. The stock is available for purchase during regular market hours through online brokers, traditional brokerages, or investment apps.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts